Astonea Labs IPO: Price, Overview, And GMP

Astonea Labs IPO- Complete Overview

Astonea Labs IPO under the SME IPO category is a book build issue of Rs. 37.67 Cr from Astonea Labs Limited. It was founded in 2017. The company acts as a Contract manufacturer of pharmaceutical & cosmetic products for companies in and outside India.

It produces and sells several antibiotic medicines, cold remedies containing antihistamines, diabetes, arterial, gynecologic disorders, and some other treatments.

It also develops skin, tooth, and hair care items in the form of gels, creams, serums, and trade packaging as well as raw materials for the pharmaceutical, cosmetic industries according to the standards of those industries.

It provides contract manufacturing of pharmaceuticals and cosmetics; sells its own under the brands "Glow Up" & " Regero ", eyeing to enter into "Avicel", exports to countries like Iraq, and Yemen.

Produts and Offerings:

Brands Products: Sells "Glow Up" Skincare & "Regero" Pharma Products (Diverse, affordable Solutions for all)

Contract manufacturing products: The company produces pharmaceuticals and cosmetics on contract, primarily for the domestic as well as export markets. 

 

Astonea Labs IPO Overview

The Astonea Labs IPO will be available from May 27, 2025, to May 29, 2025. 

The Rs. 37.67 Cr new SME IPO comprises a wholly fresh issue of 27.90 lac Shares. 

The upcoming IPO allotment date is on May 30. The Astonea Labs IPO price is Rs. 128 to Rs. 135 for each Share. 

The Astonea Labs IPO listing date is Jun 03, 2025 (expected) and listing at the BSE and SME.

Click to open demat account and apply for the IPO.

 

 

Company Financial

(Amount in Lac)

Period	31 Dec 2024	31 Mar 2024	31 Mar 2023
Total Assets	96.52	80.89	64.28
Total Revenue	69.69	80.29	67.26
PAT	4.10	3.81	0.67
Net Worth	17.28	11.97	8.16
Reserves & Surplus	9.56	4.37	4.16
Borrowings	49.48	42.40	35.99

 

Cash Flows

(Amount in lac)

Net Cash Flow in Multiple Activities	31 Dec 2024	31 Mar 2024	31 Mar 2023
Net Cash Flow Operating Activities	278.53	404.77	(105.09)
Net Cash Flow Investing Activities	(846.41)	(718.26)	(308)
Net Cash Flow Financing Activities	562.24	345.33	413.99

 

The Objective of the Issue

• Financing of the costs that are anticipated to be required in order to register in Bolivia, South America.

• On the second floor of the existing premises, purchase and install equipment and plant for producing ointments for export in compliance with international standards, marketing, advertising, and branding.

• The cost of purchasing software and hardware

•  Meeting the needs for working capital.

• General corporate purposes.

 

Explore to check your IPO application status.

Peers of Astonea Labs Ltd.

Company Name	Face Value (Rs.)	EPS (Rs.)	P/E (x)
Beta Drugs Limited	10	37.9	49

 

Evaluation

Astonea Labs IPO price is Rs. 128 to Rs. 135 for each Share.

Evaluation of P/E Ratio

Considering the FY ended 31 Mar 2025 with an EPS of Rs. 5.01 from the last year, the resulting P/E ratio is 26.94x.

Considering the weighted EPS of Rs. 2.85 for the last three years, the P/E ratio is 47.36x.

Scoda Tubes IPO is available for subscription.

Comparative Analysis With Listed Peers

The average P/E Ratio of the logistics industry based on listed peers is 49.

Particulars	P/E Ratio (x)
Highest	49
Lowest	49
Average	49

In simple words, the P/E ratio of this IPO (26.94x), compared with the industry’s average P/E of 49x, has an undervaluation (on a P/E ratio basis only). Hence, the price of the Share seems fairly priced for the investors when considered based on the average P/E ratio of the industry.

 

 

IPO's Strengths

• Good marketing & distribution network.

• A seasoned management team.

• Extensive product range.

• High-quality, highly innovative products are a market competitiveness.

 

IPO’s Weaknesses

• The obligation of a Fund to cater for at the national level.

• Captive market share & existing in limited niches.

• Reliance on economic activities and rivalry from domestic as well as foreign companies.

 

Astonea Labs IPO GMP

Astonea Labs IPO GMP is Rs. 0 as of 26 May 2025, while writing this information. The Astonea Labs IPO listing price is Rs. 135 (estimated).

IPO Timetable (Tentative)

The Astonea IPO date of application is starting from May 27 to May 29, 2025, allotment on May 30, refund initiation on Jun 02, and listing on Jun 03, 2025.

Events	Date
IPO Opening Date	May 27, 2025
IPO Closing Date	May 29, 2025
IPO Allotment Date	May 30, 2025
Refund Initiation	Jun 02, 2025
IPO Listing Date	Jun 03, 2025

 

Astonea Labs IPO Details 

The IPO with a Face Value of Rs. 10 per share offers a total issue size of 27,90,000 Shares (Rs. 37.67 Cr).

IPO Opening & Closing date	27 May, 2025 to 29 May, 2025
Face Value	Rs. 10 per Share
Issue Price	Rs. 128 to Rs. 135 per Share.
Lot Size	1000 Shares
Issue Size	27,90,000 Shares (Rs. 37.67 Cr)
Offer for Sale	-
Fresh Issue	27,90,000 Shares (Rs. 37.67 Cr)
Listing at	BSE, SME
Issue Type	Book Building Issue
Registrar	Kfin Technologies Limited

 

 

IPO Lot Details 

The IPO allows retail investors to invest in a minimum and maximum of 1 Lot (1000 Shares) amounting to Rs. 1,35,000 and in multiples thereof, while for HNI investors, the minimum Lot is 2 (2000 Shares) amounting to Rs. 2,70,000.

Minimum Lot Investment (Retail)	1 Lot
Maximum Lot Investment (Retail)	1 Lot
HNI (Min)	2 Lots

 

The Aegis Vopak Terminals IPO application is available now.

 

IPO Reservation (% of Net Issue)

Institutional’s Portion	50%
Retail’s Portion	35%
Non-Institutional’s Portion	15%

 

Promoters And Management of Astonea Labs Ltd.

• Ashish Gulati.

Pre-Issue Promoter Shareholding	98.42%
Post-Issue Promoter Shareholding	-

 

IPO Lead Managers

• Oneview Corporate Advisors Pvt. Ltd.
  
  

Dividend Policy

The company has not paid a dividend in the last three fiscal years.

 

 

Conclusion

Astonea Labs IPO provides an investment outlook for investors wishing exposure to the pharmaceutical and cosmetic sector at its mere beginnings. Rising on solid fundamentals and innovative products, the IPO looks to be at or near fair value. 

 

Finowings IPO Analysis

Hope you enjoyed the Finowings IPO Analysis. We tried our best to give every required detail about the company that you should know before applying to the IPO. 

You must consult your financial advisor before making any financial decisions. 

To Apply for the IPO, Click Here.

To Read the Prospectus of the Company Click Here to Download the DRHP.

Click Here To Stay Updated With The Upcoming IPOs.

DISCLAIMER: This blog is NOT any buy or sell recommendation. No investment or trading advice is given. The content is purely for educational and information purposes only. Always consult your eligible financial advisor for investment-related decisions.